Second malignancies in patients with essential thrombocythaemia.
作者： M. L. Randi , F. Fabris , A. Girolami
DOI: 10.1111/J.1365-2141.2002.3346_1.X
关键词: Oncology 、 Internal medicine 、 In patient 、 Medicine
摘要:
sci-hub.st 参考文章(4)
H Iland, P Peterson, J Laszlo, S Murphy, Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Seminars in Hematology. ,vol. 34, pp. 29- 39 ,(1997)
Guido Finazzi, Marco Ruggeri, Francesco Rodeghiero, Tiziano Barbui, Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial. British Journal of Haematology. ,vol. 110, pp. 577- 583 ,(2000) , 10.1046/J.1365-2141.2000.02188.X
M. L. Randi, F. Fabris, A. Girolami, Leukemia and Myelodysplasia Effect of Multiple Cytotoxic Therapy in Essential Thrombocythemia Leukemia & Lymphoma. ,vol. 37, pp. 379- 385 ,(2000) , 10.3109/10428190009089438
Sergio Cortelazzo, Guido Finazzi, Marco Ruggeri, Oscar Vestri, Monica Galli, Francesco Rodeghiero, Tiziano Barbui, Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis The New England Journal of Medicine. ,vol. 332, pp. 1132- 1136 ,(1995) , 10.1056/NEJM199504273321704